Synergistic activity of polymyxin B combined with vancomycin against carbapenem-resistant and polymyxin-resistant Acinetobacter baumannii: first in vitro study

被引:16
|
作者
Shinohara, Danielle Rosani [1 ]
Menegucci, Thatiany Cevallos [1 ]
Fedrigo, Nayara Helisandra [1 ]
Migliorini, Leticia Busato [1 ]
Carrara-Marroni, Floristher Elaine [2 ]
dos Anjos, Marcia Maria [1 ]
Cardoso, Celso Luiz [1 ]
Belini Nishiyama, Sheila Alexandra [1 ]
Bronharo Tognim, Maria Cristina [1 ]
机构
[1] Univ Estadual Maringa, Ave Colombo 5790, BR-87020900 Maringa, Parana, Brazil
[2] Univ Estadual Londrina, Rodovia Celso Garcia Cid,Pr 445 Km 380, BR-86057970 Londrina, Parana, Brazil
关键词
Acinetobacter baumannii; polymyxin B; vancomycin; drug combinations; MUTANT PREVENTION CONCENTRATIONS; COLISTIN-RESISTANT; COMBINATION; STRAINS; AGENTS;
D O I
10.1099/jmm.0.000920
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Purpose. The effect of a combination of polymyxin B (PMB) and vancomycin (VAN) was assessed against six Acinetobacter baumannii clinical isolates belonging to six different clusters (three PMB-susceptible and three PMB-resistant). Methodology. The synergistic effect of the PMB-VAN combination was determined with the checkerboard, time-kill, disk-diffusion and M.I.C.Evaluator assays. PMB-resistance was investigated with mcr-1 gene amplification and a mutant frequency assay. Results. In the checkerboard assay, all PMB-resistant isolates showed a synergistic effect. The time-kill assay demonstrated that the PMB-VAN combination had a bactericidal effect at 24 h against isolates with a high mutant rate for PMB, suggesting that this combination may block the hypermutation of some isolates. No antagonism was detected. All PMB-resistant isolates also showed synergism in the disk-diffusion test, and a significant decrease in VAN MICs in the M.I.C.Evaluator assay. Conclusion. Our findings indicate that the PMB-VAN combination has a synergistic effect on A. baumannii, especially against PMB-resistant isolates.
引用
收藏
页码:309 / 315
页数:7
相关论文
共 50 条
  • [1] In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii
    Zhang, Hui
    Zhu, Yunzhu
    Yang, Ning
    Kong, Qinxiang
    Zheng, Yahong
    Lv, Na
    Chen, Haoran
    Yue, Chengcheng
    Liu, Yanyan
    Li, Jiabin
    Ye, Ying
    [J]. INFECTION AND DRUG RESISTANCE, 2021, 14 : 4657 - 4666
  • [2] Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity
    Lenhard, Justin R.
    Thamlikitkul, Visanu
    Silveira, Fernanda P.
    Garonzik, Samira M.
    Tao, Xun
    Forrest, Alan
    Shin, Beom Soo
    Kaye, Keith S.
    Bulitta, Juergen B.
    Nation, Roger L.
    Li, Jian
    Tsuji, Brian T.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (05) : 1415 - 1420
  • [3] In Vitro Pharmacodynamics of Polymyxin B and Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii
    Hagihara, Mao
    Housman, Seth T.
    Nicolau, David P.
    Kuti, Joseph L.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) : 874 - 879
  • [4] In-Vitro Activity of Polymyxin B, Rifampicin, Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii in Singapore
    Lim, Tze-Peng
    Tan, Thean-Yen
    Lee, Winnie
    Sasikala, S.
    Tan, Thuan-Tong
    Hsu, Li-Yang
    Kwa, Andrea L.
    [J]. PLOS ONE, 2011, 6 (04):
  • [5] Antibiofilm effect of biogenic silver nanoparticle alone and combined with polymyxin B against carbapenem-resistant Acinetobacter baumannii
    Allend, Suzane Olachea
    Garcia, Marcelle de Oliveira
    da Cunha, Kamila Furtado
    Albernaz, Deborah Trota Farias
    Panagio, Luciano Aparecido
    Nakazato, Gerson
    Reis, Guilherme Fonseca
    Oliveira, Thais Larre
    SeixasNeto, Amilton Clair Pinto
    Hartwig, Daiane Drawanz
    [J]. BRAZILIAN JOURNAL OF MICROBIOLOGY, 2024,
  • [6] Performance of Rapid Polymyxin™ NP and Rapid Polymyxin™ Acinetobacter for the detection of polymyxin resistance in carbapenem-resistant Acinetobacter baumannii and Enterobacterales
    Kon, Hadas
    Abramov, Shirin
    Ben Dalak, Maayan Amar
    Elmaliach, Noy
    Schwartz, David
    Carmeli, Yehuda
    Lellouche, Jonathan
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (06) : 1484 - 1490
  • [7] Semi-mechanistic PK/PD modelling of combined polymyxin B and minocycline against a polymyxin-resistant strain of Acinetobacter baumannii
    Aranzana-Climent, V.
    Buyck, J. M.
    Smani, Y.
    Pachon-Diaz, J.
    Marchand, S.
    Couet, W.
    Gregoire, N.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2020, 26 (09) : 1254.e9 - 1254.e15
  • [8] Polymyxin-Resistant Acinetobacter baumannii: Urgent Action Needed
    Pogue, Jason M.
    Cohen, David A.
    Marchaim, Dror
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 60 (09) : 1304 - 1307
  • [9] Synergistic effects of polymyxin and vancomycin combinations on carbapenem- and polymyxin-resistant Klebsiella pneumoniae and their molecular characteristics
    Nwabor, Ozioma Forstinus
    Chukamnerd, Arnon
    Terbtothakun, Pawarisa
    Nwabor, Lois Chinwe
    Surachat, Komwit
    Roytrakul, Sittiruk
    Voravuthikunchai, Supayang Piyawan
    Chusri, Sarunyou
    [J]. MICROBIOLOGY SPECTRUM, 2023,
  • [10] Comparative pharmacodynamics of four different carbapenems in combination with polymyxin B against carbapenem-resistant Acinetobacter baumannii
    Lenhard, Justin R.
    Gall, Jonathan S.
    Bulitta, Jurgen B.
    Thamlikitkul, Visanu
    Landersdorfer, Cornelia B.
    Forrest, Alan
    Nation, Roger L.
    Li, Jian
    Tsuji, Brian T.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2016, 48 (06) : 719 - 724